(Q38521988)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Gerasimos S Christodoulatos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

1 reference

1 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

Hormone Molecular Biology and Clinical Investigation

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

5-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Impact of serum adiponectin and leptin levels in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Multifaceted roles of adiponectin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Battling the hematological malignancies: the 200 years' war.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin in insulin resistance: lessons from translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

T-cadherin is essential for adiponectin-mediated revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

A prospective study of circulating adipokine levels and risk of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin signals through Adiponectin Receptor 1 to reverse imatinib resistance in K562 human chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Survival and proliferation factors of normal and malignant plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin deficiency suppresses lymphoma growth in mice by modulating NK cells, CD8 T cells, and myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Paracrine and endocrine effects of adipose tissue on cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Sleep apnea as a comorbidity in obese psoriasis patients: a cross-sectional study. Do psoriasis characteristics and metabolic parameters play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin, a Fat Cell Product, Influences the Earliest Lymphocyte Precursors in Bone Marrow Cultures by Activation of the Cyclooxygenase-Prostaglandin Pathway in Stromal Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Obesity, weight gain, and risk of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin in relation to childhood myeloblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin is produced by lymphocytes and is a negative regulator of granulopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin as a routine clinical biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adipocyte-derived players in hematologic tumors: useful novel targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Increased adiposity and altered adipocyte function in female survivors of childhood acute lymphoblastic leukaemia treated without cranial radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FHMBCI-2015-0016

21 January 2018

Identifiers

DOI

10.1515/HMBCI-2015-0016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26057219%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference